Lv54
1141 积分 2021-11-22 加入
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
2天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
3天前
已完结
China’s Clinical Trial Boom
5天前
已关闭
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China
6天前
已完结
Clinical Efficacy and Safety of CD7-Targeted CAR T Cell Therapy for T-cell Malignancies: A Systematic Review and Meta-analysis
6天前
已完结
Estimate of multiple myeloma patients by line of therapy in the USA: population-level projections 2020-2025
7天前
已完结
How I individualize treatment for chronic-phase CML
12天前
已关闭
Allogeneic transplantation for aplastic anemia
14天前
已完结
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia
14天前
已完结
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
15天前
已完结
皖公网安备34019202002308
